Facilitated By

San Antonio Medical Foundation

PHASE IB TRIAL OF ENCAPSULATED RAPAMYCIN (ERAPA) IN PROSTATE CANCER PATIENTS UNDER ACTIVE SURVEILLANCE

UT Health San Antonio

The UT Health San Antonio, with missions of teaching, research and healing, is one of the country’s leading health sciences universities.

Principal Investigator(s)
Liss, Michael A
Funded by
RAPAMYCIN HOLDINGS, INC.
Research Start Date
Status
Active
Collaborative Project
Clinical Care
Drug Discovery
Cancer